ArticleCureus2025
Management of Panurethral Strictures by Preputial Graft Urethroplasty: Outcomes From a Tertiary Care Centre.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective The aim of the study was to review our outcomes with preputial graft urethroplasty for panurethral strictures in a small subset of the Indian population. Patients and methods We conducted a retrospective review of case records of the patients who had undergone preputial graft urethroplasty in our center from July 2022 to July 2023. Parameters such as uroflowmetry and maximal urine flow rate (Qmax) before surgery and at 1 month, 6 months, and 1 year after surgery, International Index of Erectile Function (IIEF) before and after surgery, intraoperative length of stricture, intraoperative time, length of hospital stay, postoperative course and complications and recurrences were recorded and analyzed. This spiral prepuceal graft was developed from preputial skin 5 cm wide, which is harvested in the shape of a helix and can reach up to 25 cm in length. Results A total of 15 patients were included in this study. All 15 patients were chronic smokers and pan chewers and hence were not ideal candidates for buccal mucosal graft. Four patients had previously undergone buccal mucosal urethroplasty. The preoperative mean Qmax was 4.99 ± 1.70 mL/s. At the time of catheter removal at 1 month, Qmax improved significantly to 19.37 ± 4.16 mL/s (t = 10.412, p <0.001). After 1 year, the mean postoperative Qmax decreased slightly to 17.37 ± 5.03 mL/s (t = 3.196, p = 0.006) but remained higher than the pre-surgery levels. Five patients had Clavien Dindo Grade I complications such as penile edema (n=1), scrotal hematoma (n=1), epididymorchitis (n=1), penile skin necrosis (n=1), and fever (n=1). None of the patients had recurrence at a follow-up of 1 year. Conclusion The preputial spiral graft urethroplasty is a safe procedure for panurethral strictures, those with previous urethral surgeries, those with unsuitable oral mucosa, and an alternative to buccal mucosal graft urethroplasty and two-stage urethroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.